THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Naoko Takebe to Protein Tyrosine Phosphatase, Non-Receptor Type 11

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Protein Tyrosine Phosphatase, Non-Receptor Type 11.
Naoko Takebe
Connection Strength
0.061
Protein Tyrosine Phosphatase, Non-Receptor Type 11
  1. RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types. Cancer Res Commun. 2025 Oct 01; 5(10):1779-1795.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES